Clarity Clinical Solutions Blog

Clinical research explained, plainly.

Randomized Controlled Trials Explained: Why They're the Gold Standard

2026-08-15 · Tags: randomized controlled trials, RCT, clinical trials, randomization, placebo, drug development

Why can't doctors just choose who gets the new treatment? Why do we flip a coin? The answer is bias, and it is more powerful than you think.

This video from Clarity Clinical Solutions explains why randomization and control groups are the foundation of trustworthy medical research.

The problem: human judgment contaminates results

Without randomization, human judgment contaminates the results in three ways:

Randomization solves all three problems at once.

Choosing vs. chance

The difference between selection bias and random allocation is the difference between choosing and chance.

When doctors choose, they unconsciously put healthier patients in the treatment group, making the drug look better than it really is. With random allocation, a computer or coin flip assigns each patient to treatment or control. This makes the groups as similar as possible except for the drug itself.

It is like flipping a coin: each patient has a 50-50 chance of receiving the drug or placebo. Large trials use computer-generated random sequences. Block randomization ensures balanced group sizes by randomizing in small blocks: for a block of four, two get drug and two get placebo, but the order is random.

The key principle: randomization ensures the only systematic difference between groups is the treatment.

Why we need a control group

There are three reasons:

  1. Natural recovery. Many conditions improve on their own.
  2. Regression to the mean. Patients join trials when symptoms are worst, and symptoms naturally fluctuate.
  3. The placebo effect. Belief alone produces measurable improvement.

    4. A control group captures all three of these non-drug effects. Without it, you would attribute every improvement to the drug.

    There are two main types of control groups:

    • Placebo control is used when no effective treatment exists. Half get the new drug, half get an inactive placebo. The difference is the true drug effect.
    • Active control is used when an effective treatment already exists. The new drug is compared to the current standard of care. This ensures patients are never denied a working treatment.

    Double blinding: hide who gets what

    Randomization alone is not enough. We must also hide who gets what. In a double-blind design, neither the patient nor the doctor knows who receives the real drug. The placebo looks, tastes, and smells identical.

    This prevents both patient expectations and doctor assessments from biasing the results. In an emergency, the code can be broken, but this is rare.

    Stratification for small trials

    For small trials, chance alone might not balance important factors. Stratified randomization first groups patients by key characteristics: age, sex, disease severity. Then it randomizes within each group.

    Without stratification, a small trial could end up with all the smokers in the treatment group, distorting the results. Stratification ensures balance on the variables that matter most.

    Why not just use historical controls?

    Comparing to patients from last year's medical records fails for four reasons:

    1. Better care over time. Patients today receive better supportive care than patients five years ago.
    2. Different diagnosis criteria. How we define a disease changes.
    3. Missing data. Old records lack measurements we now consider important.
    4. Unmeasured confounders. You cannot control for factors you did not measure.

      5. You cannot randomize retrospectively.

      A real example: hormone replacement therapy

      For decades, observational studies suggested hormone replacement therapy reduced heart disease in women by 30 to 50%. Doctors prescribed it widely.

      When the Women's Health Initiative, a large randomized trial, found that HRT actually increased heart disease risk by 29%, the observational data was shown to be completely wrong. Millions of women were affected.

      The limitations

      Randomized trials are powerful, but not perfect:

      • They are expensive. Phase 3 trials average $20 to $100 million.
      • They are slow. Recruiting thousands of patients takes years.
      • Generalization is limited. Strict eligibility criteria may exclude the very patients who need the drug most.

      These limitations are why not every medical question can be answered with an RCT.

      When RCTs aren't possible

      When RCTs are not possible, researchers use alternatives:

      • Observational studies analyze naturally occurring differences using cohort and case-control designs.
      • N-of-1 trials give a single patient drug and placebo at different times in a blinded fashion.
      • Real-world evidence from electronic health records is increasingly accepted by the FDA for post-market decisions.

      Why the RCT is the gold standard

      The randomized controlled trial is the gold standard for four reasons:

      1. It eliminates selection bias by distributing unknown confounders equally.
      2. It controls for time, so both groups experience the same period and medical advances.
      3. It allows double blinding, removing expectation bias.
      4. It enables statistical testing. The p-value and confidence interval depend on randomization. Without it, the math does not work.

        5. The bottom line

        Randomization eliminates human bias by letting chance decide who gets treatment. Control groups allow us to measure the true drug effect against natural recovery and the placebo effect. Double blinding removes expectation bias from both patients and doctors.

        The randomized controlled trial is the gold standard because it gives us answers we can trust.

        This article is based on the Clarity Clinical Solutions video "Randomized Controlled Trials Explained: Why They're the Gold Standard." Watch it here: Randomized Controlled Trials Explained: Why They're the Gold Standard

        References

        1. Clarity Clinical Solutions — "Randomized Controlled Trials Explained: Why They're the Gold Standard" (video, source of the trial design concepts and examples). https://www.youtube.com/watch?v=UrpRB3S_xvI
        2. ClinicalTrials.gov — Learn about clinical studies (how trials work and why randomization matters). https://clinicaltrials.gov/
        3. NIH — The placebo effect and why trials use controls (National Center for Complementary and Integrative Health). https://www.nccih.nih.gov/health/placebo-effect
          4. 🎬 Watch the video: Randomized Controlled Trials Explained: Why They're the Gold Standard

          ← Back to all posts